OR4K15 inhibitors function through various biochemical mechanisms to affect the signaling and activity of this olfactory receptor. Metals such as copper and zinc act as allosteric modulators, binding to specific sites on the receptor that can impair ligand binding or receptor conformation. The receptor's activity is also contingent on the proper membrane environment; cholesterol extraction by certain compounds disrupts the lipid raft domains, leading to a decrease in receptor function. Additionally, altering intracellular cAMP levels can desensitize the receptor, thereby reducing its activity. Other inhibitors operate by interfering with the G-protein signaling cascade. For instance, some compounds can inhibit specific G-protein subunits or disrupt the association between G-proteins and their coupled receptors, leading to an attenuation of the receptor's signaling efficacy.
Furthermore, some inhibitors target the recycling and internalization processes of G-protein-coupled receptors, which are essential for receptor resensitization and response to new stimuli. Toxins that target G-proteins can inhibit the receptor's signaling by preventing the activation of downstream effectors. Certain blockers that target related receptor families can indirectly influence OR4K15 by modulating the shared signaling pathways. Inhibitors of other G-protein-coupled receptors, such as cannabinoid or vanilloid receptors, may also have off-target effects that reduce the functional activity of OR4K15. Finally, a few compounds can inhibit signaling molecules that act downstream of the receptor, which is critical for the full cellular response to the receptor's activation, thereby effectively reducing the receptor's functionality without directly interacting with the receptor itself.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Copper(II) sulfate | 7758-98-7 | sc-211133 sc-211133A sc-211133B | 100 g 500 g 1 kg | $45.00 $120.00 $185.00 | 3 | |
Copper ions bind to histidine residues on G-protein coupled receptors, which could impair the ligand binding on OR4K15. | ||||||
Zinc | 7440-66-6 | sc-213177 | 100 g | $47.00 | ||
Zinc ions have been shown to act as allosteric inhibitors of G-protein-coupled receptors, potentially affecting OR4K15. | ||||||
Methyl-β-cyclodextrin | 128446-36-6 | sc-215379A sc-215379 sc-215379C sc-215379B | 100 mg 1 g 10 g 5 g | $25.00 $65.00 $170.00 $110.00 | 19 | |
Removes cholesterol from cell membranes, possibly disrupting the membrane environment essential for OR4K15 function. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
Activates adenylate cyclase, increasing cAMP levels which can desensitize G-protein coupled receptors like OR4K15. | ||||||
Propranolol | 525-66-6 | sc-507425 | 100 mg | $180.00 | ||
As a beta-adrenergic antagonist, it may interfere with G-protein signaling cascades that OR4K15 is a part of. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $68.00 | 2 | |
Alters the acidity of intracellular vesicles, potentially impairing G-protein receptor recycling including that of OR4K15. | ||||||
Pertussis Toxin (islet-activating protein) | 70323-44-3 | sc-200837 | 50 µg | $442.00 | 3 | |
Inhibits Gi/o proteins, which could disrupt downstream signaling of OR4K15. | ||||||
Capsazepine | 138977-28-3 | sc-201098 sc-201098A | 5 mg 25 mg | $145.00 $450.00 | 11 | |
Blocks vanilloid receptors, which may indirectly affect G-protein receptor mediated pathways that OR4K15 participates in. | ||||||
JTE 907 | 282089-49-0 | sc-203616 sc-203616A | 10 mg 50 mg | $283.00 $1100.00 | ||
Inhibits the cannabinoid receptor 1 (CB1), could indirectly affect the signaling pathways associated with OR4K15. | ||||||
YM 254890 | 568580-02-9 | sc-507356 | 1 mg | $500.00 | ||
Specific Gαq inhibitor, could disrupt signaling pathways downstream of OR4K15. | ||||||